HA-966 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces N-methyl-D-aspartate (NMDA)-mediated brain damage.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Neuroscience Letters

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2682393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model.

  1989cited by this paper
• Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phosphonovalerate (D-AP5) on rat cortical slices.

  1988cited by this paper
• Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists

  1988cited by this paper
• Systemic approaches to modifying quinolinic acid striatal lesions in rats

  1988cited by this paper
• Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.

  1988cited by this paper
• 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex.

  1988cited by this paper
• [3H]MK801 binding to the NMDA receptor/ionophore complex is regulated by divalent cations: evidence for multiple regulatory sites.

  1988cited by this paper
• Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system.

  1988cited by this paper
• 3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine.

  1987cited by this paper
• Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil

  1987cited by this paper
• Glycine potentiates the NMDA response in cultured mouse brain neurons

  1987cited by this paper
• Glycine potentiates N-methyl-D-aspartate-induced [3H]TCP binding to rat cortical membranes.

  1987cited by this paper

• Pathophysiology: General Principles

  2018cites this paper
• Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges

  2017cites this paper
• Desenvolvimento de novos antagonistas do recetor NMDA

  2014cites this paper
• Comparison of the effects of perinatal and neonatal administration of sodium ferulate on repair following excitotoxic neuronal damages induced by maternal oral administration of monosodium glutamate at a late stage of pregnancy

  2012cites this paper
• Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain.

  2006cites this paper
• Glycine and neuroprotective effect of hypothermia in hypoxic-ischemic brain damage.

  2002cites this paper
• Perinatal brain injury: from pathogenesis to neuroprotection.

  2001cites this paper
• Effects of ( 1 )-HA-966 , CGS-19755 , Phencyclidine , and Dizocilpine on Repeated Acquisition of Response Chains in Pigeons : Systemic Manipulation of Central Glycine Sites 1 , 2

  1999cites this paper
• Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites.

  1999cites this paper
• Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

  1998cites this paper
• Free D-aspartate and D-serine in the mammalian brain and periphery.

  1997cites this paper
• gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats.

  1997cites this paper
• Glycine Antagonists for Treatment of Ischemic Brain Injury

  1997cites this paper
• The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeys.

  1996cites this paper
• Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: Functional implications for treatment of parkinsonian symptoms

  1995cites this paper
• In vivo Models of Cerebral Ischemia: Effects of Parenterally Administered NMDA Receptor Glycine Site Antagonists

  1995cites this paper
• The Severity of Naloxone-Precipitated Opiate Withdrawal Is Attenuated by Felbamate, a Possible Glycine Antagonist

  1995cites this paper
• The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential.

  1994cites this paper
• MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicity.

  1993cites this paper
• Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats.

  1993cites this paper
• Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists.

  1993cites this paper
• Indole-2-carboxylates, novel antagonists of the N-methyl-D-aspartate (NMDA)-associated glycine recognition sites: in vivo characterization.

  1993cites this paper
• Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy.

  1992cites this paper
• Overview: Excitatory Amino Acids; Current Opinion in Therapeutic Patents June 1992

  1992cites this paper
• Intra- and extracellular changes of amino acids in the cerebral cortex of the neonatal rat during hypoxic-ischemia.

  1991cites this paper
• Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo.

  1991cites this paper
• Routine screen for Wilson's disease?

  1990cites this paper
• BMY-14802 antagonizes harmaline- and D-serine-induced increases in mouse cerebellar cyclic GMP: neurochemical evidence for a sigma receptor-mediated functional modulation of responses mediated by the N-methyl-D-aspartate receptor complex in vivo.

  1990cites this paper
• Pharmacology of N‐methyl‐D‐aspartate‐induced brain injury in an in vivo perinatal rat model

  1990cites this paper
• Physiological and pathophysiological roles of excitatory amino acids during central nervous system development.

  1990cites this paper
• Characterization and regional distribution of strychnine-insensitive [3H]glycine binding sites in rat brain by quantitative receptor autoradiography.

  1990cites this paper
• Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats.

  1990cites this paper
• Nonketotic hyperglycinemia: Pathophysiological role of NMDA‐type excitatory amino acid receptors

  1990cites this paper